HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Takemi Tanaka Selected Research

Phosphotransferases (Kinase)

6/2022EWI2 prevents EGFR from clustering and endocytosis to reduce tumor cell movement and proliferation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Takemi Tanaka Research Topics

Disease

28Neoplasms (Cancer)
06/2022 - 09/2003
12Breast Neoplasms (Breast Cancer)
01/2022 - 02/2009
8Neoplasm Metastasis (Metastasis)
03/2020 - 10/2010
4Ovarian Neoplasms (Ovarian Cancer)
03/2016 - 05/2010
3Carcinoma (Carcinomatosis)
01/2013 - 06/2009
2Circulating Neoplastic Cells
01/2018 - 12/2016
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2018 - 10/2004
1Residual Neoplasm
03/2020
1Macular Degeneration (Age-Related Maculopathy)
03/2018
1Cicatrix (Scar)
01/2018
1Inflammation (Inflammations)
08/2017
1Hypoxia (Hypoxemia)
10/2016
1Lymphoma (Lymphomas)
09/2013
1Hodgkin Disease (Hodgkin's Disease)
08/2013
1Non-Hodgkin Lymphoma (Lymphosarcoma)
08/2013
1Sclerosis
08/2013
1Acidosis
01/2013
1Diabetic Cardiomyopathies
05/2011
1Hyperglycemia
05/2011
1Arteriosclerosis
01/2008
1Hematologic Diseases (Blood Diseases)
10/2004
1Lung Neoplasms (Lung Cancer)
10/2004
1Hyperplasia
09/2003
1Papilloma (Papillomatosis)
09/2003
1Carcinogenesis
09/2003

Drug/Important Bio-Agent (IBA)

8E-SelectinIBA
03/2020 - 09/2010
5Proteins (Proteins, Gene)FDA Link
06/2018 - 01/2007
4Biomarkers (Surrogate Marker)IBA
06/2018 - 08/2013
3Hormones (Hormone)IBA
10/2021 - 06/2015
3Messenger RNA (mRNA)IBA
06/2018 - 12/2014
3Estrogen ReceptorsIBA
08/2017 - 01/2013
3Small Interfering RNA (siRNA)IBA
01/2013 - 06/2009
2Doxorubicin (Adriamycin)FDA LinkGeneric
03/2020 - 02/2009
2ProlactinIBA
06/2018 - 01/2013
2Pharmaceutical PreparationsIBA
03/2018 - 02/2009
2Phenobarbital (Luminal)FDA Link
12/2016 - 01/2013
2Serine Proteases (Serine Protease)IBA
03/2016 - 12/2014
2Complementary DNA (cDNA)IBA
03/2016 - 01/2007
2Liposomes (Liposome)IBA
01/2013 - 04/2011
2SiliconIBA
01/2013 - 05/2010
2Oncogene Proteins (Oncogene Protein)IBA
01/2013 - 05/2010
2Retinoid X Receptors (Retinoid X Receptor)IBA
05/2011 - 10/2007
2Retinoic Acid Receptors (Retinoic Acid Receptor)IBA
05/2011 - 10/2007
21,2-oleoylphosphatidylcholine (DOPC)IBA
05/2010 - 06/2009
1TetraspaninsIBA
06/2022
1IntegrinsIBA
06/2022
1Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
06/2022
1Phosphotransferases (Kinase)IBA
06/2022
1Androgen Receptors (Androgen Receptor)IBA
06/2018
1pegaptanib (Macugen)FDA Link
03/2018
1MicroRNAs (MicroRNA)IBA
10/2016
1AnnexinsIBA
10/2016
1prostasinIBA
03/2016
1SelectinsIBA
01/2016
1Kallikreins (Kallikrein)IBA
12/2014
1Peptide Hydrolases (Proteases)FDA Link
12/2014
1AntigensIBA
12/2014
1Synthetic DrugsIBA
09/2013
1Proteasome Endopeptidase Complex (Proteasome)IBA
09/2013
1UbiquitinIBA
09/2013
1Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA
08/2013
1Syndecan-1 (Syndecan 1)IBA
08/2013
1Growth Hormone (Somatotropin)IBA
01/2013
1Epidermal Growth Factor (EGF)IBA
01/2013
1Prolactin Receptors (Prolactin Receptor)IBA
01/2013
1Tyrosine (L-Tyrosine)FDA Link
01/2013
1Estrogen Receptor Modulators (Antiestrogen)IBA
01/2013
1Facilitative Glucose Transport Proteins (Glucose Transporter)IBA
01/2013
1Oncostatin MIBA
01/2013
1Antineoplastic Agents (Antineoplastics)IBA
10/2010
1Hyaluronic Acid (Hyaluronan)IBA
10/2010
1AcidsIBA
10/2010
1CytokinesIBA
05/2010
1Cisplatin (Platino)FDA LinkGeneric
06/2009
1PlatinumIBA
06/2009
1Paclitaxel (Taxol)FDA LinkGeneric
02/2009
1Biological ProductsIBA
02/2009
1AlbuminsIBA
02/2009
1TeaIBA
01/2008
1LigandsIBA
10/2007
1Indicators and Reagents (Reagents)IBA
01/2007
1Angiogenesis InhibitorsIBA
10/2004
1PPAR gammaIBA
10/2004
1Thalidomide (Thalomid)FDA Link
10/2004
1Differentiation AntigensIBA
09/2003
1RetinoidsIBA
09/2003

Therapy/Procedure

7Therapeutics
03/2018 - 10/2007
4Intravenous Administration
03/2020 - 04/2011
2Drug Therapy (Chemotherapy)
03/2020 - 06/2009
2Intravenous Injections
12/2016 - 06/2015
1Adjuvant Chemotherapy
01/2022
1Segmental Mastectomy (Lumpectomy)
10/2021
1Radiotherapy
01/2018
1Aftercare (After-Treatment)
01/2018
1Chemoradiotherapy
01/2018